Back to results
US 12,364,702 B2Granted
Highly active sting protein agonist compound
AssigneeAdlai Nortye Biopharma Co., Ltd.
InventorsYufeng Chen, Kaixuan Chen, Pan Li, Canfeng Liu, Ji Wang, Qingchong Qiu, Yang Lu
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds of Formula (I) or (II), pharmaceutical compositions thereof, and methods of using compounds of Formula (I) or (II) to prevent and/or treat immune-related disorders.
Claims13
A compound having a structure of Formula (I) or (II),
- wherein W1 represents (CRaRa′)s, any one CRaRa′ is optionally substituted by 0, 1 or 2 O, S or NRb, or any one CRaRa′ is optionally taken together to form —C═O;
- W2 represents (CRhRh′)t, wherein any one CRhRh′ is optionally substituted by 0, 1 or 2 O, S or NR, or any one CRhRh′ is optionally taken together to form —C═O:
- s and t each independently consist of an integer selected from 1, 2, and 3;
- q is selected from 0 and 1;
- r is selected from 0 and 1;
- and
- q and r are not 0 at the same time;
- wherein R1, R2, R3, and R4 each independently represent hydrogen, halogen, cyano, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —ORc, —O—(C1-C6 alkylene)-NRcRc′, —NRcRc′, —OC(O)Rc, —C(O)Rc, —CO2R, —CON(Rc)(Rc′), —C(═NH)N(Rc)(Rc′), —NRcC(O)Rc′, —SO2Rc, —SO2NRcRc′, —N(Rc)—SO2—(C1-C6 alkyl)-NRcRc′, —N(Rc)—C(O)—(C1-C6 alkyl)-NRcRc′, —NRcS(O)Rc′, —NRcSO2Rc′, —O—P(O)(ORc)(ORc′), 6- to 12-membered aryl or 5- to 12-membered heteroaryl;
- R5 and R6 are each independently selected from hydrogen or C1-C6 alkyl;
- wherein when q=0, QA1 is each independently selected from the group consisting of hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —(C0-C6 alkyl)-(C3-C6 cycloalkyl), —(C0-C6 alkyl)-(4- to 6-membered heterocyclyl), —(C0-C6 alkyl)-(6- to 12-membered aryl), and —(C0-C6 alkyl)-(5- to 12-membered heteroaryl);
- or QA1 and R5 together with atoms adjacent thereto form a 3- to 6-membered ring optionally containing 0, 1 or 2 heteroatoms selected from O, N and S;
- QA2 is each independently selected from the group consisting of hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —(C0-C6 alkyl)-(C3-C6 cycloalkyl), —(C0-C6 alkyl)-(4- to 6-membered heterocyclyl), —(C0-C6 alkyl)-(6- to 12-membered aryl), and —(C0-C6 alkyl)-(5- to 12-membered heteroaryl);
- or QA2 and R6 together with atoms adjacent thereto, form a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N, and S:
- when q=1, -QA1-A-QA2- is taken together to form a linking group selected from:
- —C1-C6 alkylene-, —C2-C6 alkenylene-, —C2-C6 alkynylene-, —(C0-C6 alkylene)-O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)—(C0-C6 alkylene)-, —C(O)—(C0-C6 alkylene)-O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-OC(O)—(C0-C6 alkylene)-, —(C0-C6 alkylene)-NRc—C(O)—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)—NRc—(C0-C6 alkylene)-, —(C0-C6 alkylene)-NRc—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-(C3-C6 carbocyclyl)-(C0-C6 alkylene)-, —(C0-C6 alkylene)-(4- to 6-membered heterocyclyl)-(C0-C6 alkylene)-, —(C0-C6 alkylene)-(6- to 12-membered aryl)-(C0-C6 alkylene)-, and —(C0-C6 alkylene)-(5- to 12-membered heteroaryl)-(C0-C6 alkylene)-;
- wherein when r=0, QB1 and QB2 are each independently selected from the group consisting of hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —(C0-C6 alkyl)-(C3-C6 cycloalkyl), —(C0-C6 alkyl)-(4- to 6-membered heterocyclyl), —(C0-C6 alkyl)-(6- to 12-membered aryl), and —(C0-C6 alkyl)-(5- to 12-membered heteroaryl);
- when r=1, -QB1-B-QB2- is taken together to form a linking group selected from:
- —C1-C6 alkylene-, —C2-C6 alkenylene-, —C2-C6 alkynylene-, —(C0-C6 alkylene)-O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)—(C0-C6 alkylene)-, —C(O)—(C0-C6 alkylene)-O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-OC(O)—(C0-C6 alkylene)-, —(C0-C6 alkylene)-NRc—C(O)—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)—NRc—(C0-C6 alkylene)-, —(C0-C6 alkylene)-NRc—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-(C3-C6 carbocyclyl)-(C0-C6 alkylene)-, —(C0-C6 alkylene)-(4- to 6-membered heterocyclyl)-(C0-C6 alkylene)-, —(C0-C6 alkylene)-(6- to 12-membered aryl)-(C0-C6 alkylene)-, and —(C0-C6 alkylene)-(5- to 12-membered heteroaryl)-(C0-C6 alkylene)-;
- RI and RII each independently represent hydrogen or C1-C6 alkyl;
- wherein Ra, Ra′, Rh and Rh′ each independently represent hydrogen, halogen, hydroxy, C1-C6 alkyl, C1-C6 alkylthio, —(C0-C6 alkylene)-(C3-C6 cycloalkyl), —(C0-C6 alkylene)-(4- to 6-membered heterocyclyl), —(C0-C6 alkylene)-(6- to 12-membered aryl), —(C0-C6 alkylene)-(5- to 12-membered heteroaryl), —NRdRd′, —NRdCORd′, —NRdS(O)Rd′, —NRdSO2Rd′, —OR, or —OCORd;
- Rb and Rj each independently represent hydrogen, C1-C6 alkyl, C3-C6 cycloalkyl, —(C0-C6 alkylene)-(6- to 12-membered aryl), —C(O)Re, —SORe, —SO2Re, —C(O)ORe, or —C(O)NReRe′;
- Rc and Rc′ each independently represent hydrogen, C1-C6 alkyl, —(C0-C6 alkylene)-(C3-C6 cycloalkyl), or —(C0-C6 alkylene)-(4- to 6-membered heterocyclyl);
- or Ra and Ra′ together with the atom bound thereto are optionally cyclized to each other into a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N and S;
- or Rc and Rc′ together with the atom bound thereto are optionally cyclized to each other into a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N and S;
- or Rh and Rh′ together with the atom bound thereto are optionally cyclized to each other into a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N and S:
- wherein m=1, 2, 3 or 4;
- n=1, 2 or 3;
- o=1 or 2;
- and
- p=1 or 2;
- or when m=2, the two adjacent R1 and the atom bound thereto are optionally cyclized to each other into a 5- to 8-membered ring optionally containing 0, 1 or 2 heteroatoms selected from O, N and S;
- or when n=2, the two adjacent R2 and the atom bound thereto are optionally cyclized to each other into a 5- to 8-membered ring optionally containing 0, 1 or 2 heteroatoms selected from O, N and S;
- or when p=2, the two adjacent R4 and the atom bound thereto are optionally cyclized to each other into a 5- to 8-membered ring optionally containing 0, 1 or 2 heteroatoms selected from O, N and S;
- any alkyl, alkoxy, alkenyl, alkynyl, alkylene, aryl, heteroaryl, carbocyclyl, heterocyclyl defined above are optionally substituted by 0, 1, 2, 3, or 4 substituents selected from:
- C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halogen, sulfo, cyano, 3- to 8-membered carbocyclyl, 3- to 8-membered heterocyclyl, 6- to 12-membered aryl, 5- to 12-membered heteroaryl, nitro, oxo, C1-C6 mercapto, C1-C6 alkoxy, —ORf, —C(O)—ORf, —OC(O)Rf, —S(O)Rf, —S(O)2Rf, —S(O)2NRfRf′, —OCONRfRf′, —NRfCORf′, —NRfS(O)Rf′, —NRfS(O)2Rf′, —NRfC(O)ORf′, —CONRfRf′, —NRfRf′, —NHC═NHNRfRf′, C1-C6 haloalkyl, C1-C6 haloalkoxy, and —O—P(O)(ORf)(ORf′);
- wherein Rd, Rd′, Re, Re′, Rf, and Rf′ each independently represent hydrogen or C1-C6 alkyl, wherein the C1-C6 alkyl is also optionally substituted by C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halogen, sulfo, cyano, 3- to 8-membered carbocyclyl, 3- to 8-membered heterocyclyl, 6- to 12-membered aryl, 5- to 12-membered heteroaryl, nitro, oxo, C1-C6 mercapto, C1-C6 alkoxy, —ORg, —C(O)—ORg, —OC(O)Rg, —S(O)Rg, —S(O)2Rg, —S(O)2NRgRg′, —NRgCORg′, —NRgS(O)Rg′, —NRgS(O)2Rg′, —NRgC(O)ORg′, —CONRgRg′, —NRgRg′, C1-C6 haloalkyl, C1-C6 haloalkoxy, or —O—P(O)(ORg)(ORg′);
- or Rd, Rd′, Re, Re′, Rf, and Rf′ together with the nitrogen atom bound thereto form a 5- to 8-membered carbocycle or a 5- to 8-membered heterocycle;
- wherein Rg and Rg′ are each independently selected from hydrogen or C1-C6 alkyl.
35 more elements
Dependencies are inferred from the claim text.